Tonix Pharmaceuticals Holding (TNXP) Operating Leases (2019 - 2026)
Tonix Pharmaceuticals Holding (TNXP) posted quarterly Operating Leases of $1.3 million for Q1 2026, up 129.13% year-over-year from $563000.0 in Q1 2025, and up 8.95% quarter-over-quarter from $1.2 million in Q4 2025.
Tonix Pharmaceuticals Holding (TNXP) Operating Leases (2019 - 2026) Analysis & Trends
Tonix Pharmaceuticals Holding's Operating Leases history runs 8 years deep, the most recent figure standing at $1.3 million for Q1 2026.
- In Q1 2026, Operating Leases rose 129.13% year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at $1.3 million (up 129.13% YoY), while the FY2025 annual figure was $1.2 million, up 230.73% from the prior year.
- Operating Leases for Q1 2026 stood at $1.3 million, up from $1.2 million in the prior quarter.
- The five-year high for Operating Leases was $1.3 million in Q1 2026, with the low at $297000.0 in Q2 2025.
- The 5-year median for Operating Leases is $563000.0 (2024), against an average of $628176.5.
- The sharpest annual moves came in 2024 and 2025: Operating Leases slumped 45.1% in 2024, then surged 230.73% in 2025.
- Tonix Pharmaceuticals Holding's Operating Leases stood at $328000.0 in 2022, then jumped by 92.68% to $632000.0 in 2023, then slumped by 43.35% to $358000.0 in 2024, then soared by 230.73% to $1.2 million in 2025, then advanced by 8.95% to $1.3 million in 2026.
- Business Quant data shows TNXP's Operating Leases at $1.3 million in Q1 2026, $1.2 million in Q4 2025, and $425000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Tonix Pharmaceuticals Holding | 213.43 Mn | 213.43 Mn | 12.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.27 Mn |
| Mar 31, 2026 | 1.29 Mn |
| Dec 31, 2025 | 1.18 Mn |
| Sep 30, 2025 | 425,000.00 |
| Jun 30, 2025 | 297,000.00 |
| Mar 31, 2025 | 563,000.00 |
| Dec 31, 2024 | 358,000.00 |
| Sep 30, 2024 | 700,000.00 |
| Jun 30, 2024 | 493,000.00 |
| Mar 31, 2024 | 563,000.00 |
| Dec 31, 2023 | 632,000.00 |
| Sep 30, 2023 | 898,000.00 |
| Jun 30, 2023 | 898,000.00 |
| Mar 31, 2023 | 528,000.00 |
| Dec 31, 2022 | 328,000.00 |
| Sep 30, 2022 | 386,000.00 |
| Jun 30, 2022 | 334,000.00 |
| Mar 31, 2022 | 802,000.00 |
| Dec 31, 2021 | 467,000.00 |
| Sep 30, 2021 | 467,000.00 |